Please add "" to your Email Address Book. Learn how.

Tell Congress to Take Action Now.
Participate in the National Call-In on June 26

» Learn more.
Find a Clinical Trial
Learn more about pancreatic cancer clinical trials and find one that you may be eligible for in your area.
Tips for Managing Side Effects
Find out about side effects commonly experienced with pancreatic cancer treatments.
Nine Chances
to Stride

Plan to attend one of our nine PurpleStride awareness events held in communities across the country this June. Find out more.
The first-ever American Association for Cancer Research special conference devoted to pancreatic cancer is set for June 18 to 21.
Customize Your Awareness Items
ShopPurple merchandise can now be customized. Visit our store today and personalize your special gifts.
Bill Gains Support of Half the Senate
S. 362 now has 50 Senate sponsors! Help move the bill forward by participating in the Three Week Challenge starting June 11.
Keep the
Memory Alive

Create a tribute page for your loved one and help others facing pancreatic cancer.
Double Your
Donation Power

Many employers match charitable contributions made by their employees. Learn more about matching gifts.

A Message from the President and CEO

Our guest columnist for Pancreas Matters this month is David Tuveson, MD, PhD, Senior Group Leader at the CRUK Cambridge Research Institute in England. Dave received one of our first research grants in 2003 and joined our Scientific Advisory Board (SAB) in 2006. He has served as the Chair of the SAB for the past two years. His Chair term ends on June 30 and we'd like to offer our deep appreciation for his leadership and service on the SAB. Dave now has an exciting opportunity to move back to the United States and lead a pancreatic cancer lab at Cold Spring Harbor; he will also assume a new role as director of research at the Lustgarten Foundation. We are proud of Dave's accomplishments and look forward to working with him in his new roles.

In related news, Dr. Anirban Maitra will begin serving as Chair of the SAB effective July 1. Anirban will serve as our guest columnist for the July edition of
Pancreas Matters .

With warm regards,

Julie Fleshman, JD, MBA
President and CEO
Pancreatic Cancer Action Network

Dear Pancreatic Cancer Action Network Friends:

With heartfelt admiration, I bid you farewell from the Scientific Advisory Board of one of the best advocacy groups I have ever encountered: the Pancreatic Cancer Action Network.

When I was a young medical student in the 1980s, I became incensed at a new disease killing many of my patients, and thus I had the opportunity to meet clinical and lay advocates who tirelessly plotted strategies to combat the scourge of AIDS. From the late '80s to the mid '90s there was a wave of change in the fight against AIDS with the arrival of triple therapy, huge research funding increases, and a heightened public awareness of the disease due to a very active and effective advocacy movement.



For information about including the Pancreatic Cancer Action Network in your estate planning,
click here.


Privacy Policy       Unsubscribe